N-(2,3,4-Tri-O-acetyl-6-deoxy-α-L-mannopyranos -1-yl) thiourea (5)
Gaseous ammonia was passed through a solution of 4 ( 3.31 g, 10 mmol) in anhydrous THF (50 mL) for 1 h. Compound 5 was obtained as a white solid after removal of solvent in vacuum ( 3.3 g, 99 %) and used in the next step without further purification. 1 
Synthesis of the title hapten glycopeptide 1
After a mixture of 2-Cl-trityl-Cl resin (400.0 mg, active Cl, 0.20 mmol), Fmoc-Leu-OH ( 354.0 mg, 1.0 mmol) and DIEA (365.0 μL) in DMF (5 mL) was shaken on a vortex mixer at rt overnight, the resin was filtered off and washed several times with MeOH, DCM and DMF.
The Leu-linked resin was then used for the construction of full length peptide/glycopeptides.
The protocols employed were: deprotection of Fmoc with 20% piperidine in DMF (15 min) and peptide coupling using 5 eq. of amino acid, 4.5 eq. of HCTU and 10 eq. of DIEA. All coupling reactions were set to perform 1 h at rt. Amino acids Fmoc-Gly-OH, Fmoc-Orn(Aloc)-OH, Fmoc-Gly-OH, Fmoc-Cys-OH, and AcOH were sequentially installed to construct peptide after removal of allyloxycarbonyl group on the resin. Then, a solution of compound 6 (3 eq.), Et 3 N (10 eq.) and AgNO 3 (3 eq.) in 5 mL of anhydrous DMF was added into the resin.
After the mixture was shaken for 8 h in the dark, the resultant mixture was filtered and the resin was washed thoroughly with DMF, MeOH, and DCM to compound 8. To remove the acetyl groups from the glycopeptide on the resin, the peptide-loaded resin was treated with a mixture of NH 2 -NH 2 in DMF (5 %, 10 mL) for 10 h at rt. The resin was filtered off and washed thoroughly with DMF, H 2 O, MeOH, and DCM. Then, the peptide-loaded resin was treated with a mixture of TIPS/TFA (5:95, 10 mL) for 2 h at rt. The resin was filtered off and washed with TFA. The washings were combined and condensed in vacuum to give crude 1.
The crude product was dissolved in water and purified by HPLC (conditions: Grace Vydac "Peptide C18", 250 X 10 mM, 10 μm particle size, suitable ratio of acetonitrile-0.1%TFA in water-0.1%TFA, 4 mL/min) to give 1 (18.0 mg, isolated yield 27 %) as a white solid. 1 instrument using an analytical column (Grace Vydac "Protein & Peptide C18", 250 X 4.6 mM, 5 μm particle size, flow rate 1.0 mL/min, rt). Solution A was 0.1% TFA in water, and solution B was 0.1% TFA in MeCN. Gradient for a-e: A linear gradient of 10% to 10% B over 2 min, then a linear gradient of 10% to 90% B over 25 min.
X-ray crystallography of compound 5
Single crystal of compound 5 was obtained by slow evaporation of dichloromethane/nhexane solution of 5 at room temperature. The X-ray single crystal diffraction data for 5 was collected on Bruker APEX DUO diffractometers with M Kα radiation ( = 0.71073 Å) at 298  2 K in the -2scanning mode. The structures were solved by direct methods using the SHELXS-97 program 6 and refined by full-matrix least-squares techniques (SHELXL-97) on
Anisotropic thermal parameters were assigned to all non-hydrogen atoms. The organic hydrogen atoms were generated geometrically. CCDC-1469830 contains the supplementary crystallographic data for this paper. These data can be obtained free of charge from the Cambridge Crystallographic Data Center via www.ccdc.cam.ac.uk/data_request/cif. 
Methods for antibody generation and purification

Conjugation of glycopeptides to BSA
Glycopeptides were conjugated with Bovine serum albumin (BSA) for inoculation and ELISA analysis, respectively, using Sulfo-GMBS as the crosslinker by following the manufacturer's instruction. BSA was mixed with indicated peptides at a molecular ratio of 1:1.
Rabbit immunization
Two rabbits (male, 2-2.5 Kg) were immunized three times at three-week intervals. P1(Rha)-BSA was injected together with the complete and incomplete form of Freund's adjuvant for the 1st and 2nd/3rd immunization, respectively. For each immunization 2 mg peptide was used. Serum samples were collected prior to immunization (pre-bleed) and 1 week after the final immunization for subsequent analyses.
Affinity purification of antibody
Firstly, the crude anti sera were purified over Protein A Sepharose 4B fast flow. 
